Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Aziza

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|March 16, 2011
How to achieve synergy between volume replacement and filling products for global facial rejuvenationHervé Raspaldo, Richard Aziza, Lakhdar Belhaouari, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2018
IDEAL 2a Phase II Study of Ultrafocal Brachytherapy for Low- and Intermediate-risk Prostate CancerPierre Graff, Daniel Portalez, Amélie Lusque, et al.
Breast (Edinburgh, Scotland)|July 12, 2021
Diagnosis, biology and epidemiology of oligometastatic breast cancerJean-Louis Lacaze, Richard Aziza, Ciprian Chira, et al.
Journal of Clinical Medicine|December 1, 2020
MRI Characteristics Accurately Predict Biochemical Recurrence after Radical ProstatectomyCécile Manceau, Jean-Baptiste Beauval, Marine Lesourd, et al.
Urology|January 4, 2020
Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic BiopsiesGuillaume Ploussard, Jean-Baptiste Beauval, Marine Lesourd, et al.
World Journal of Urology|June 15, 2019
Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillanceGuillaume Ploussard, Jean-Baptiste Beauval, Marine Lesourd, et al.
The Journal of Urology|June 28, 2019
Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance ImagingGuillaume Ploussard, Jean-Baptiste Beauval, Marine Lesourd, et al.
World Journal of Urology|October 16, 2019
Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological studyGuillaume Ploussard, Jean-Baptiste Beauval, Marine Lesourd, et al.
Breast (Edinburgh, Scotland)|May 12, 2023
Erratum to 'Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes' [The Breast (2023) 102-109]Gauthier Glemarec, Jean-Louis Lacaze, Bastien Cabarrou, et al.
Urologic Oncology|April 22, 2020
Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesionsCécile Manceau, Mathieu Roumiguié, Marine Lesourd, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|March 16, 2011
How to achieve synergy between volume replacement and filling products for global facial rejuvenationHervé Raspaldo, Richard Aziza, Lakhdar Belhaouari, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2018
IDEAL 2a Phase II Study of Ultrafocal Brachytherapy for Low- and Intermediate-risk Prostate CancerPierre Graff, Daniel Portalez, Amélie Lusque, et al.
Breast (Edinburgh, Scotland)|July 12, 2021
Diagnosis, biology and epidemiology of oligometastatic breast cancerJean-Louis Lacaze, Richard Aziza, Ciprian Chira, et al.
Journal of Clinical Medicine|December 1, 2020
MRI Characteristics Accurately Predict Biochemical Recurrence after Radical ProstatectomyCécile Manceau, Jean-Baptiste Beauval, Marine Lesourd, et al.
Urology|January 4, 2020
Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic BiopsiesGuillaume Ploussard, Jean-Baptiste Beauval, Marine Lesourd, et al.
World Journal of Urology|June 15, 2019
Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillanceGuillaume Ploussard, Jean-Baptiste Beauval, Marine Lesourd, et al.
The Journal of Urology|June 28, 2019
Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance ImagingGuillaume Ploussard, Jean-Baptiste Beauval, Marine Lesourd, et al.
World Journal of Urology|October 16, 2019
Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological studyGuillaume Ploussard, Jean-Baptiste Beauval, Marine Lesourd, et al.
Breast (Edinburgh, Scotland)|May 12, 2023
Erratum to 'Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes' [The Breast (2023) 102-109]Gauthier Glemarec, Jean-Louis Lacaze, Bastien Cabarrou, et al.
Urologic Oncology|April 22, 2020
Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesionsCécile Manceau, Mathieu Roumiguié, Marine Lesourd, et al.
Pageof 3